Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect

por Siler, Thomas M, LaForce, Craig F, Kianifard, Farid, Williams, James, Spangenthal, Selwyn
Publicado 2014